AVADEL PHARMACEUTICALS PLC — Director's Dealing 2017

Oct 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVADEL PHARMACEUTICALS PLC (AVDL)
CIK: 0001012477
Period of Report: 2017-10-10

Reporting Person: Elrod Marcus W (See Remarks)

Holdings (Non-Derivative)

Security	Shares	Ownership
ADSs	3400	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$13.59	2026-08-10	ADSs (100000)	100000	Direct
Stock Option (right to buy)	$10.4	2026-12-14	ADSs (22000)	22000	Direct

Footnotes

F1: The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.

F2: Represents 3,400 restricted ADSs granted under the issuer's "Free Share" award program on 12/14/2016, all of which will be issued to the reporting person on the second anniversary of the grant date.

F3: Options become exercisable as to 25,000 ADSs on each of August 10, 2017, 2018, 2019 and 2020, provided that the reporting person continues to be employed by the issuer or an affiliate thereof.

F4: Options become exercisable as to 5,500 ADSs on each of the first four anniversaries after the 12/14/2016 grant date.